Adderall or Nothing The Story There’s officially an Adderall shortage. Catch me up. Adderall is used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. For months, the prescription drug has been hard to come by. And yesterday, the FDA acknowledged the shortage. It said the US’s largest supplier, Teva, has been struggling to meet growing demand among a labor shortage and supply chain issues. And that competitors also aren’t keeping up. Now, the FDA says the US’s 6 million ADHD patients should start asking their doctors about other treatment options until supply’s back up — an issue that could last until March. Did you say ‘6 million’? Yup. And that’s just kids between 3 and 17 years old — 62% of whom take ADHD medication. And even though it’s most common in kids, over 4% of US adults have been diagnosed with the disorder. Those who use Adderall rely on it to help with things like finishing tasks, homework, and remembering routine safety or hygiene issues like whether you brushed your teeth or turned off the stove. Now, losing access to the medication can lead to symptoms like fatigue, depression, and sleep problems. It all comes amid a broader awareness of ADHD… Go on. This month is ADHD Awareness Month. Social media is opening up a dialogue about the disorder — and it shows. The hashtag #adhd has more than 11 billion views on TikTok. And experts say videos about ADHD symptoms on TikTok have encouraged people to go for evaluations — which can go underdiagnosed in women and girls. The pandemic has also forced people to take their mental health more seriously. If you’re having trouble focusing at work, communicating in a relationship, or keeping your home organized you can talk to a therapist or psychiatrist who specializes in ADHD about an evaluation. theSkimm The surging demand for Adderall has created a shortage of the drug that's relied on by millions. And not taking the drug can lead to a whole other set of issues. But options are limited while manufacturers restore supplies. And Also...This Who’s being called up… Former President Trump. Yesterday, the House Committee investigating the Jan 6 attack on the Capitol voted to subpoena Trump. In the first hearing since July, the committee continued to build its case that Trump tried to overturn the election. Except now, the panel's vice chair, Rep. Liz Cheney (R-WY), is demanding answers from “the man who set this all in motion.” Trump called the committee a “total bust." But didn't say if he'd comply. Other allies including Steven Bannon and former trade adviser Peter Navarro have defied past subpoenas. It’s the last time the committee will make its case ahead of the midterms. But if the House majority flips in next month’s midterms, the subpoena — and the Jan 6 committee — could be over. …Oh and speaking of Trump, SCOTUS rejected his emergency petition to allow a special master to review about 100 classified docs that were seized from Mar-a-Lago. Trump's lawyers say granting the special master this access would help determine if the confidential docs were "personal records or presidential records.” The SCOTUS decision does not affect the DOJ's criminal investigation. Where there’s been a decision… The Parkland trial. Yesterday, a jury recommended that the 2018 Parkland shooter be sentenced to life in prison without parole. It was the deadliest mass shooting to reach a trial in the US and the decision was not without controversy. Three of the jurors voted against the death penalty — a decision that needs to be unanimous. One potential reason: fetal alcohol spectrum disorder. The defense argued that the shooter’s mother drank and smoked heavily during pregnancy — and that it contributed to his violent behavior. Now, some welcomed the decision as support for the death penalty in the US continues to fall. Others — including parents of the victims and Gov. Ron DeSantis (R) — called it a miscarriage of justice. The judge is expected to issue the jury’s recommendation during sentencing next month. Another tragedy: Yesterday, a gunman opened fire at a walking trail in eastern Raleigh, NC, killing five people and injuring at least two more. One person is in custody after a more than three-hour manhunt. Police have not released a motive. Mayor Mary-Ann Baldwin said the city needs to “come together” to support those who “have suffered a terrible loss.” Where there’s progress… Dementia. Yesterday, new research found that it may be possible to spot signs of dementia as early as nine years before receiving an official diagnosis. The trick: looking at a patient's history. On cognitive tests, people who went on to develop Alzheimer’s scored lower on tasks like problem-solving, memory, and reaction times. They also suffered from a greater number of falls and had poorer overall health (think: high blood pressure, not enough exercise). The findings are key because there are few effective treatments for dementia. And researchers think waiting for symptoms to develop is part of the problem. Now, this study hopes better awareness of warning signs may help those most at risk of developing dementia enroll in clinical trials, earlier. While Social Security recipients are set to get a bump in benefits… Netflix is dropping prices. Yesterday, the streaming giant unveiled “Basic with Ads.” Starting Nov. 3, the new ad-supported plan will run you $6.99. The main difference from the company's current $9.99 a month basic plan? That there will be an average of four to five minutes of commercials per hour. Are you still watching? Why we’re booking our flu shots… The season is apparently already upon us. What’s giving us an excuse to free the nip… BPA in sports bras. Who’s the duo you didn’t see coming… Ray J and Kanye West.